Hantz Financial Services, Inc. Abb Vie Inc. Transaction History

Hantz Financial Services, Inc.

$6.6 Billion
Q3 2025

A detailed history of Hantz Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 44,463 shares of ABBV stock, worth $10.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

44,463

Previous 43,977 1.11%

Holding current value

$10.4 Million

Previous $8.16 Million 26.12%

% of portfolio

0.16%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$184.85 - $231.54 $89,837 - $112,528	486 Added 1.11%	44,463 $10.3 Million
Q2 2025 Aug 04, 2025	SELL	$170.16 - $206.27 $227,333 - $275,576	-1,336 Reduced 2.95%	43,977 $8.16 Million
Q1 2025 May 12, 2025	SELL	$169.2 - $216.66 $120,977 - $154,911	-715 Reduced 1.55%	45,313 $9.49 Million
Q4 2024 Jan 23, 2025	SELL	$164.99 - $203.87 $299,786 - $370,431	-1,817 Reduced 3.8%	46,028 $8.18 Million
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $244,940 - $297,998	-1,495 Reduced 3.03%	47,845 $9.45 Million

Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $7.64 Million - $8.92 Million	49,340 New	49,340 $8.46 Million
Q1 2024 Aug 06, 2024	SELL	$159.82 - $182.1 $540,830 - $616,226	-3,384 Reduced 6.16%	51,577 $9.39 Million
Q4 2023 Aug 06, 2024	SELL	$137.6 - $154.97 $517,788 - $583,152	-3,763 Reduced 6.41%	54,961 $8.52 Million
Q3 2023 Aug 06, 2024	BUY	$133.59 - $154.65 $53,168 - $61,550	398 Added 0.68%	58,724 $8.75 Million
Q2 2023 Aug 06, 2024	BUY	$132.51 - $164.9 $20,804 - $25,889	157 Added 0.27%	58,326 $7.86 Million
Q1 2023 Aug 06, 2024	BUY	$144.61 - $166.54 $81,849 - $94,261	566 Added 0.98%	58,169 $9.27 Million
Q4 2022 Aug 06, 2024	BUY	$138.31 - $165.87 $514,236 - $616,704	3,718 Added 6.9%	57,603 $9.31 Million
Q3 2022 Aug 06, 2024	BUY	$134.21 - $153.93 $159,307 - $182,714	1,187 Added 2.25%	53,885 $7.23 Million
Q2 2022 Aug 06, 2024	BUY	$137.62 - $174.96 $319,278 - $405,907	2,320 Added 4.61%	52,698 $8.07 Million
Q1 2022 Aug 06, 2024	SELL	$131.98 - $163.75 $2.1 Million - $2.61 Million	-15,940 Reduced 24.04%	50,378 $8.17 Million
Q4 2021 Aug 06, 2024	SELL	$107.43 - $135.93 $7,520 - $9,515	-70 Reduced 0.11%	66,318 $8.98 Million
Q3 2021 Aug 06, 2024	BUY	$106.4 - $120.78 $1.02 Million - $1.16 Million	9,599 Added 16.9%	66,388 $7.16 Million
Q2 2021 Aug 06, 2024	BUY	$105.21 - $117.21 $284,277 - $316,701	2,702 Added 5.0%	56,789 $6.4 Million
Q1 2021 Aug 06, 2024	BUY	$102.3 - $112.62 $485,618 - $534,607	4,747 Added 9.62%	54,087 $5.85 Million
Q4 2020 Aug 06, 2024	SELL	$80.49 - $108.67 $18,190 - $24,559	-226 Reduced 0.61%	36,775 $3.94 Million
Q3 2020 Aug 06, 2024	SELL	$85.91 - $100.83 $66,580 - $78,143	-775 Reduced 2.05%	37,001 $3.24 Million
Q2 2020 Aug 06, 2024	BUY	$73.37 - $98.18 $58,622 - $78,445	799 Added 2.16%	37,776 $3.71 Million
Q1 2020 Aug 06, 2024	SELL	$64.5 - $97.79 $797,413 - $1.21 Million	-12,363 Reduced 25.06%	36,977 $2.82 Million

Others Institutions Holding ABBV

# of Institutions

4,488

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Abb Vie Inc. Transaction History